IRulya Therapeutics (IRLA) Income After Tax (2018 - 2026)
IRulya Therapeutics (IRLA) posted Profit After Tax of -$75.51 million for Q2 2026, compared with -$16.05 million a year earlier.
Powered by 
Analysis
IRulya Therapeutics (IRLA) Income After Tax (2018 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, Profit After Tax at IRulya Therapeutics was -$92.5 million; for FY2025, it was -$83.98 million.
- In prior years, IRulya Therapeutics' Profit After Tax was -$56.83 million in FY2024, -$31.39 million in FY2023 and -$51.66 million in FY2022.
- The Q2 2026 figure stands as the lowest quarterly Profit After Tax in data going back to Q1 2018.
- According to Business Quant data, Profit After Tax for the three prior quarters was $35.91 million (Q1 2026), -$39.46 million (Q4 2025) and -$13.44 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income After Tax (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,261.99 Bn | 1,235.61 Bn | 20.46 Bn | 6.45 Bn |
| 2 | Johnson & Johnson | 678.93 Bn | 598.79 Bn | 17.30 Bn | 210.00 Mn |
| 3 | AbbVie | 518.29 Bn | 486.30 Bn | 13.12 Bn | 4.22 Bn |
| 4 | Merck | 365.98 Bn | 328.92 Bn | 13.19 Bn | 5.07 Bn |
| 5 | Novartis Ag | 316.85 Bn | 290.09 Bn | - | - |
| 6 | Astrazeneca | 293.40 Bn | 267.29 Bn | 13.26 Bn | 4.80 Bn |
| 7 | Amgen | 251.78 Bn | 203.43 Bn | 7.58 Bn | 3.86 Bn |
| 8 | Gilead Sciences | 210.61 Bn | 185.71 Bn | 6.73 Bn | 2.43 Bn |
| 9 | Pfizer | 166.87 Bn | 114.23 Bn | 12.56 Bn | 3.25 Bn |
| 10 | IRulya Therapeutics | 207.35 Mn | 91.35 Mn | - | -75.51 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -75.51 Mn |
| Mar 31, 2026 | 35.91 Mn |
| Dec 31, 2025 | -39.46 Mn |
| Sep 30, 2025 | -13.44 Mn |
| Jun 30, 2025 | -16.05 Mn |
| Mar 31, 2025 | -15.03 Mn |
| Dec 31, 2024 | -12.46 Mn |
| Sep 30, 2024 | -5.49 Mn |
| Jun 30, 2024 | -27.73 Mn |
| Mar 31, 2024 | -11.15 Mn |
| Dec 31, 2023 | -8.89 Mn |
| Sep 30, 2023 | -5.35 Mn |
| Jun 30, 2023 | -4.89 Mn |
| Mar 31, 2023 | -12.25 Mn |
| Dec 31, 2022 | -5.53 Mn |
| Sep 30, 2022 | -7.92 Mn |
| Jun 30, 2022 | -16.56 Mn |
| Mar 31, 2022 | -21.64 Mn |
| Dec 31, 2021 | 66.55 Mn |
| Sep 30, 2021 | -21.71 Mn |
API Access
IRulya Therapeutics Income After Tax API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=profit-after-tax&ticker=IRLA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "profit-after-tax", "ticker": "IRLA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=profit-after-tax&ticker=IRLA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();